Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
Bio Pharma Dive
APRIL 18, 2024
Analysts had low expectations for Cerevel’s drug tavapadon, which was something of an afterthought in AbbVie’s proposed buyout of the biotech.
Thu.Apr 18, 2024
325 
Outrun Therapeutics announces launch with $10m seed funding
Pharmaceutical Technology
APRIL 18, 2024
Outrun Therapeutics announced its launch with $10m seed funding to advance a protein stabilisation pipeline focused on E3 ligase inhibitors.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo
Bio Pharma Dive
APRIL 18, 2024
It’s “early innings” in the obesity drug race, said Metsera CEO Clive Meanwell, whose company has acquired a portfolio of medicines it aims to test in combination.
Clearmind licenses psychedelic compounds for mental disorders
Pharmaceutical Technology
APRIL 18, 2024
Clearmind Medicine has entered into a licensing agreement with Yissum to develop Generation 3.0 psychedelic compounds for mental disorders.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Vertex begins bid for US approval of non-opioid painkiller
Bio Pharma Dive
APRIL 18, 2024
The start of a so-called rolling review formally begins an FDA evaluation of a closely watched drug that’s important to the biotech’s future, but faces questions about its sales potential.
Inflammation among current dementia research focus, says Alchemab CSO
Pharmaceutical Technology
APRIL 18, 2024
Inflammation, cell metabolism and neuronal health are current key areas of focus for dementia researchers, according to Jane Osbourn, chief scientific officer (CSO) at Alchemab.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
“Lack of harmonisation in Europe” hindering gene therapy growth
Pharmaceutical Technology
APRIL 18, 2024
The future of cell and gene therapy access in Europe could be more precarious than across the pond.
Novo Nordisk attracts lawmakers' scrutiny after dropping discounted insulin product Levemir
Fierce Pharma
APRIL 18, 2024
Novo Nordisk is receiving pushback from a trio of lawmakers over its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year | Novo Nordisk is receiving pushback from a trio of lawmakers on its decision to discontinue its long-acting insulin product Levemir, which was due for a steep discount at the start of the new year.
Essential Pharma acquires Reminyl from Janssen Pharmaceutica
Pharmaceutical Technology
APRIL 18, 2024
Essential Pharma has concluded the acquisition of Reminyl oral capsules from Johnson & Johnson company Janssen Pharmaceutica.
Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
Pharma Times
APRIL 18, 2024
The Tyche model could help clinicians and researchers capture crucial information in images
Weekly insulin analogues approaching approval could herald change
Pharmaceutical Technology
APRIL 18, 2024
At the ongoing Diabetes UK conference, experts highlighted the potential benefits and concerns surrounding weekly insulin candidates.
Sanofi, busy with cost-savings campaign, restructures US commercial vaccine group
Fierce Pharma
APRIL 18, 2024
During a busy period of overhaul at Sanofi, the company is restructuring its U.S. vaccine commercial group. | During a busy period of overhaul at Sanofi, the company is restructuring its U.S. vaccine commercial group. A spokesperson said the company would offer affected employees a chance to apply for new roles, plus "outplacement services.
OncoX inks licensing deal worth over $26m for NSCLC therapy
Pharmaceutical Technology
APRIL 18, 2024
OncoX will pay an upfront cost of $12.5m in cash and shares for rights to ABVC’s non-small cell lung cancer therapy, BLEX 404.
Predictions for AI in mental health in the coming year
pharmaphorum
APRIL 18, 2024
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes Dr Carl Marci, chief psychiatrist and managing director of mental health and neuroscience at OM1 to discuss predictions for AI in mental health in the coming year, as well as what might truly make a difference in the field and lessen the mental health crisis.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Chemomab touts study confirming CCL24 link to systemic sclerosis severity
Pharmaceutical Technology
APRIL 18, 2024
Higher CCL24 levels in systemic sclerosis patients have been linked to more severe forms of the condition.
Shinobi strikes deal with electronics powerhouse Panasonic to create new cell therapy manufacturing platform
Fierce Pharma
APRIL 18, 2024
History is coming full circle as induced pluripotent stem (iPS) cell-derived cell therapy maker Shinobi Therapeutics links up with Panasonic and Japan’s Kyoto University, where the first mouse iPS | Shinobi Therapeutics has entered an accord with electronics powerhouse Panasonic and Kyoto University in a bid to develop a new closed-system manufacturing device for cheaper and more efficient production of cell therapies.
Comprehensive clinical trial services
Pharmaceutical Technology
APRIL 18, 2024
Discover the key factors and latest advancements in clinical trial services to ensure the success of your clinical research. Find your comprehensive guide here.
Amgen CEO nabs pay raise thanks to Horizon deal. Does that incentivize aggressive M&A?
Fierce Pharma
APRIL 18, 2024
Amgen CEO Robert Bradway scored a 5.8% increase in overall compensation last year mostly thanks to the company’s acquisition of Horizon Therapeutics. | Amgen CEO Robert Bradway scored a 5.8% increase in overall compensation last year mostly thanks to the company's acquisition of Horizon Therapeutics.
Aligos Therapeutics gets grant for treatment of disease using compounds of formula i
Pharmaceutical Technology
APRIL 18, 2024
Discover the groundbreaking patent granted to Aligos Therapeutics Inc for compounds of Formula I, paving the way for innovative treatments and pharmaceutical compositions. Explore the potential of these compounds for treating diseases.
Omnichannel odyssey: Trends redefining marketing in 2024
pharmaphorum
APRIL 18, 2024
Embark on an omnichannel marketing odyssey by exploring the top trends reshaping the industry in 2024. Discover how chatbots, video content, and interactivity are transforming marketing strategies.
Sword Health gets grant for method for synchronizing timestamps from embedded wireless data sensors
Pharmaceutical Technology
APRIL 18, 2024
Sword Health Inc's patented method synchronizes data packets from wireless sensors to monitor patient body motion, ensuring accurate data processing.
FDA fast-tracks AskBio’s heart failure gene therapy
pharmaphorum
APRIL 18, 2024
A gene therapy for heart failure being developed by Bayer’s AskBio unit has been granted fast-track status by the FDA.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Huadong Medicine gets grant for multi-domain active protein for treating metabolic diseases
Pharmaceutical Technology
APRIL 18, 2024
Discover the groundbreaking multi-domain active protein patented by Huadong Medicine Co Ltd for treating metabolic diseases. With increased efficacy and simplified preparation process, this protein is set to revolutionize existing treatments.
Interview: Thermo Fisher Scientific's Sarah Englert on opening the doors to its new innovation hub
Outsourcing Pharma
APRIL 18, 2024
Yesterday, Thermo Fisher Scientific opened its first Innovation Lab in Center Valley, Pennsylvania., as a space where partners can come together to collaborate, innovate, and ideate on solutions to the biggest clinical supply chain pain points.
Foghorn Therapeutics gets grant for compounds for treating BAF complex-related disorders
Pharmaceutical Technology
APRIL 18, 2024
Discover the groundbreaking patent granted to Foghorn Therapeutics Inc for compounds targeting BAF complex-related disorders. Learn about the specific structure outlined in the claim and its potential in medical treatments.
Heart disease risk ‘calculator’ could save lives
pharmaphorum
APRIL 18, 2024
UK researchers describe an algorithm that is more accurate than current tools at predicting an individual’s risk of developing cardiovascular disease in the next 10 years.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Vir Biotechnology gets grant for multispecific antibodies for zika virus infection treatment
Pharmaceutical Technology
APRIL 18, 2024
Discover how Vir Biotechnology's patented multispecific antibodies target distinct Zika virus epitopes, neutralizing ZIKV infection. Explore the innovative potential for prophylaxis and treatment in this groundbreaking patent.
New UK report highlights inequalities among people living with breast cancer
Pharma Times
APRIL 18, 2024
Breast cancer was responsible for 2.
Ikena Oncology gets grant for cancer treatment method using compounds of formula i
Pharmaceutical Technology
APRIL 18, 2024
Discover the groundbreaking patent by Ikena Oncology Inc for treating cancer with specific compounds and methods. Learn how this innovative approach targets cancers with increased TEAD expression, offering hope for effective treatment.
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC
BioSpace
APRIL 18, 2024
Roche’s subsidiary Genentech has successfully expanded the label of Alecensa to include the adjuvant treatment of anaplastic lymphoma kinase-positive, early-stage non-small cell lung cancer following resection.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content